Should I Avoid Arrowhead Pharmaceuticals Inc. (ARWR)?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.
Arrowhead Pharmaceuticals Inc. (ARWR)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
Is it a Good Thing to Keep Your Arrowhead Pharmaceuticals (ARWR) Shares?
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Is Arrowhead Pharmaceuticals (ARWR) Still a Great Investment Pick?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Are Piling Into Arrowhead Pharmaceuticals Inc. (ARWR)
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...
Is Arrowhead Pharmaceuticals (ARWR) A Good Stock To Buy Now?
Baron Opportunity Fund recently published its second-quarter commentary – a copy of which can be downloaded here.
Here is What Hedge Funds Think About Arrowhead Pharmaceuticals Inc. (ARWR)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Arrowhead Pharmaceuticals (ARWR) A Smart Long-Term Buy?
Baron Funds, an asset management firm, published its “Baron Opportunity Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.
Should You Retain Your Arrowhead Pharmaceuticals (ARWR) Position?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.
Is ARWR Stock A Buy or Sell?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Is Arrowhead Pharmaceuticals (ARWR) Stock a Buy For 2021?
Baron Health Care Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
